Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The union health ministry has signed a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees (USD 205.62 million).
Aiming at a stiff vaccination target, the government has booked 30 crore doses of Hyderabad-based Biological-E's Covid vaccine, which is still in clinical trials.
URL copied Centre finalises advance deal with Hyderabad-based firm for 30 crore Covid vaccine doses The Union Ministry of Health has finalised arrangements with Hyderabad based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses. These vaccine doses will be manufactured and stockpiled by M/s Biological-E from August-December 2021. For this purpose, the Union Ministry of Health would be making an advance payment of Rs. 1500 crore to M/s Biological-E. The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trial after showin...
Centre books 30 cr doses of second made-in-India Covid vaccine from Hyderabad-based Biological-E ANI | Updated: Jun 03, 2021 10:32 IST New Delhi [India], June 3 (ANI): The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. As per a health ministry statement on Thursday, an advance payment of Rs 1,500 crore will be made to Biological-E from the Centre. This is the second made-in-India vaccine afte...
India News: The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a